HAPTOGEN LTD has a total of 48 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United Kingdom, Republic of Korea and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are I MAB BIOPHARMA US LTD, SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD and POMONA RICERCA SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | Republic of Korea | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | United States | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Australia | 3 | |
#7 | Canada | 3 | |
#8 | China | 3 | |
#9 | Japan | 3 | |
#10 | Hong Kong | 2 | |
#11 | Norway | 2 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Charlton Keith Alan | 26 |
#2 | Porter Andrew Justin Radcliffe | 23 |
#3 | Broadbent Ian | 13 |
#4 | Porter Andrew | 10 |
#5 | Charlton Keith | 9 |
#6 | Thornthwaite Lorna | 9 |
#7 | Alan Charlton Keith | 2 |
#8 | Radcliffe Porter Andrew Justin | 2 |
#9 | Porter Andrew Justin Radcliff | 2 |
#10 | Strachan Gillian | 2 |
Publication | Filing date | Title |
---|---|---|
GB0618132D0 | Method and model for testing immunogenicity | |
GB0614568D0 | Anti-testosterone antibodies | |
GB0411014D0 | Methods for the control treatment and management of obesity | |
GB0410958D0 | Methods for reducing biofilm formation in infectious bacteria | |
GB0407008D0 | Methods for inducing rapid cell death (autolysis) in infectious bacteria | |
GB0327532D0 | Specific binding molecules | |
KR20110124375A | Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody | |
GB0306783D0 | Methods for the control,treatment and management of infectious bacterial disease | |
GB0223551D0 | Methods for constructing repertoires of first members of specific binding pairs with enhanced affinity for hapten and hapten determinant target molecules | |
GB0218951D0 | Methods for the control treatment and management of infectious bacterial disea se |